β-Defensin-1 (Human)

Documents

Asp-His-Tyr-Asn-Cys-Val-Ser-Ser-Gly-Gly-Gln-Cys-Leu-Tyr-Ser-Ala-Cys-Pro-Ile-Phe-Thr-Lys-Ile-Gln-Gly-Thr-Cys-Tyr-Arg-Gly-Lys-Ala-Lys-Cys-Cys-Lys (Disulfide bonds between Cys⁵-Cys³⁴, Cys¹²-Cys²⁷, and Cys¹⁷-Cys³⁵)
: (M.W. 3928.5) C₁₆₇H₂₅₆N₄₈O₅₀S₆
: Antimicrobial Peptide

Package	Price(Yen)	Availability
Vial 0.1 mg	22,000	Ships within 1-3 business days
Bulk Request

Solubility: H₂O (0.1 mM)

K.W. Bensch, M. Raida, H.-J. Mägert, P. Schulz-Knappe, and W.-G. Forssmann, FEBS Lett., 368, 331 (1995). (Original)
M.J. Goldman, G.M. Anderson, E.D. Stolzenberg, U.P. Kari, M. Zasloff, and J.M. Wilson, Cell, 88, 553 (1997). (Pharmacol; Inactivated in Cystic Fibrosis)
T. Hiratsuka, M. Nakazato, T. Ihi, T. Minematsu, N. Chino, T. Nakanishi, A. Shimizu, K. Kangawa, and S. Matsukura, Nephron, 85, 34 (2000). (Pharmacol.)
N. Chino, S. Kubo, H. Nishio, Y. Nishiuchi, M. Nakazato, and T. Kimura, Int. J. Pept. Res. Ther., 12, 203 (2006). (Chem. Synthesis & Pharmacol.)
R.I. Lehrer and T. Ganz, Ann. N. Y. Acad. Sci., 797, 228 (1996). (Review)
M. Zasloff, Nature, 415, 389 (2002). (Review)
T. Hirsch, F. Jacobsen, H.-U. Steinau, and L. Steinstraesser, Protein Pept. Lett., 15, 238 (2008). (Review)
M. Pazgier, X. Li, W. Lu, and J. Lubkowski, Curr. Pharm. Des., 13, 3096 (2007). (Review)
Y. Lai and R.L. Gallo, Trends Immunol., 30, 131 (2009). (Review)

Data Sheet